TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07276802: The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)

Sponsor: Research Insight LLC · Phase: PHASE4 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 40 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$8,499,200

Rescue Site Savings

+$5,604,160

Unlock Full NCT07276802 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07276802 Rescue Dossier →